prikaz prve stranice dokumenta Dijagnostika i liječenje tumora mokraćnog mjehura u pasa
  Download
PDF 598.7 KB
master's thesis
Dijagnostika i liječenje tumora mokraćnog mjehura u pasa
Zagreb: University of Zagreb, Faculty of Veterinary Medicine, 2017. urn:nbn:hr:178:283379
Šijaković, Marija Nika
University of Zagreb
Faculty of Veterinary Medicine
Surgery, Orthopaedics and Ophtalmology Clinic

Institutional repository: Repository of Faculty of Veterinary Medicine

Cite this document

Šijaković, M. N. (2017). Dijagnostika i liječenje tumora mokraćnog mjehura u pasa (Master's thesis). Zagreb: University of Zagreb, Faculty of Veterinary Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:178:283379

Šijaković, Marija Nika. "Dijagnostika i liječenje tumora mokraćnog mjehura u pasa." Master's thesis, University of Zagreb, Faculty of Veterinary Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:178:283379

Šijaković, Marija Nika. "Dijagnostika i liječenje tumora mokraćnog mjehura u pasa." Master's thesis, University of Zagreb, Faculty of Veterinary Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:178:283379

Šijaković, M. N. (2017). 'Dijagnostika i liječenje tumora mokraćnog mjehura u pasa', Master's thesis, University of Zagreb, Faculty of Veterinary Medicine, accessed 17 November 2024, https://urn.nsk.hr/urn:nbn:hr:178:283379

Šijaković MN. Dijagnostika i liječenje tumora mokraćnog mjehura u pasa [Master's thesis]. Zagreb: University of Zagreb, Faculty of Veterinary Medicine; 2017 [cited 2024 November 17] Available at: https://urn.nsk.hr/urn:nbn:hr:178:283379

M. N. Šijaković, "Dijagnostika i liječenje tumora mokraćnog mjehura u pasa", Master's thesis, University of Zagreb, Faculty of Veterinary Medicine, Zagreb, 2017. Available at: https://urn.nsk.hr/urn:nbn:hr:178:283379

Metadata
TitleDijagnostika i liječenje tumora mokraćnog mjehura u pasa
Title (english)Diagnosis and Treatment of Canine Urinary Bladder Tumors
AuthorMarija Nika Šijaković
MentorBerislav Radišić (mentor)
Committee memberDamir Stanin (predsjednik povjerenstva)
Committee memberLjiljana Bedrica (član povjerenstva)
Committee memberBerislav Radišić (član povjerenstva)
GranterUniversity of Zagreb
Faculty of Veterinary Medicine
(Surgery, Orthopaedics and Ophtalmology Clinic)
Zagreb
Defense date and country2017-12-22, Croatia
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Veterinary Medicine
Abstract
Maligni tumori donjeg urinarnog trakta najčešće su u mokraćnom mjehuru te uključuju karcinom prijelaznih stanica, karcinom pločastih stanica, adenokarcinom, lejomiosarkom, fibrosarkom, hemangiosarkom i rabdomiosarkom. Čimbenici rizika koji su povezani s karcinomom mokraćnog mjehura uključuju topične insekticide, izlaganje močvarama koje su zaprašivane kemikalijama protiv komaraca, okolinu s jakom industrijskom aktivnošću, pretilost, ženski spol i pasminu. Klinička slika gotovo u potpunosti odgovara kliničkoj slici kroničnog cistitisa i mokraćnih kamenaca, što otežava pravovremenu dijagnozu. Tumori donjeg urinarnog trakta ispunjavaju prostor i često uzrokuju ulceracije sluznice, što se klinički manifestira disurijom, hematurijom i opstrukcijom. Bolest najčešće zahvaća područje trigonuma u mokraćnom mjehuru. Dijagnostika karcinoma prijelaznih stanica uz anamnezu i opći klinički pregled obuhvaća rentgensko snimanje, ultrazvuk, urinoanalizu, patohistološku i citološku pretragu uzorka, laboratorijske pretrage krvi, kompjuterizirana tomografija (CT) i magnetsku rezonanciju (MRI). Liječenje karcinoma prijelaznih stanica mokraćnog mjehura najčešće se provodi kirurškim putem, a od ostalih metoda koriste se nesteroidni protuupalni lijekovi, kemoterapeutici, radijacijska te fotodinamička terapija. Za pacijente koji su liječeni samo operacijama vrijeme preživljavanja je u prosijeku godina dana, iako upotpunjavanje terapije s lijekovima poput piroksikama i mitoksantrona može poboljšati preživljavanje. U proteklom desetljeću znanost i struka napredovale su u liječenju i prepoznavanju važnosti rane dijagnostike karcinoma prijelaznog epitela mokraćnog mjehura.
Abstract (english)
Malignant tumors of the lower urinary tract include transitional cell carcinoma, ma, fibrosarcoma squamous cell carcinoma hemangiosarcoma and rhabdomyosarcoma. Risk factors associated with bladder cancer include topical pesticides, living near marshes, environments with strong industrial activity, overweight dogs, female dogs and breed. The clinical signs are almost entirely consistent with the clinical signs of chronic cystitis and urinary stones, making it difficult for timely diagnosis. Tumors of the lower urinary tract fill the area and often cause the ulceration of mucous membrane, which is clinically manifested by dysuria, hematuria and obstruction. The disease most often affects the trigonum area in the urinary bladder. Diagnosis of transitional cell carcinoma along with anamnesis and general clinical examination include x-rays, ultrasound, urine analysis, pathohistological and cytological examination of the sample, laboratory blood tests, computerized tomography (CT) and magnetic resonance imaging (MRI). Treatment of transitional cell carcinomas is most commonly performed with operation, and other methods include nonsteroidal anti-inflammatory drugs, chemotherapy, radiation and photodynamic therapy. For patients treated only with operation, survival time has been around a year, though a combination of drug therapy such as piroxicam and mitoxantrone can improve survival time. Over the past decade, science has been advancing in the treatment and recognition of the importance of early diagnosis of transitional cell carcinoma.
Keywords
Keywords (english)
Languagecroatian
URN:NBNurn:nbn:hr:178:283379
Study programmeTitle: Veterinary Medicine
Study programme type: university
Study level: integrated undergraduate and graduate
Academic / professional title: doktor/doktorica veterinarske medicine (doktor/doktorica veterinarske medicine)
Type of resourceText
File originBorn digital
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2018-07-23 12:42:53